| Name | LXRβ agonist-3 |
|---|
| Description | LXRβ agonist-3 (compound 4-13) is a potent and selective LXRβ (liver X receptor β) agonist, with an EC50 of 0.095 μM. LXRβ agonist-3 efficiently inhibits U87EGFRvIII cell, with an IC50 of 3.75 μM. LXRβ agonist-3 shows antitumor activity, and can inhibit glioblastoma[1]. |
|---|---|
| Related Catalog | |
| Target |
EC50: 0.095 ± 0.012 μM (LXRβ) 0.277 ± 0.066 μM (LXRα)[1] |
| In Vivo | LXRβ agonist-3 (compound 4-13) (BALB/c mice, 50 mg/kg, IP, daily for 15 days) significantly reduces glioblastoma tumor growth[1]. |
| References |
| Molecular Formula | C30H33N3O6S |
|---|---|
| Molecular Weight | 563.66 |